Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,159 JPY | -1.09% | +2.62% | +2.59% |
May. 14 | FDA extends review of Ascendis Pharma's hormone disorder therapy | RE |
May. 14 | Scilex Holding Says Federal Court Approved Settlement With Takeda Pharmaceutical in Gloperba Patent Dispute | MT |
ETFs positioned on Takeda Pharmaceutical Company Limited
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
24.44% | 19 M€ | +11.51% | ||
5.00% | 288 M€ | +23.83% | ||
3.80% | 1,531 M€ | +20.75% | ||
3.43% | 240 M€ | +15.33% | ||
3.26% | 60 M€ | +21.62% | ||
1.68% | 14 M€ | +17.02% | ||
1.65% | 9,760 M€ | +17.18% | ||
1.65% | 4,929 M€ | +16.34% | ||
1.50% | 70 M€ | +16.33% | ||
1.50% | 0 M€ | 0.00% | - | |
1.38% | 17 M€ | +11.76% | - | |
1.38% | 63,295 M€ | +16.72% | - | |
1.38% | 20,360 M€ | +15.55% | - | |
1.38% | 140,441 M€ | +16.69% | ||
1.34% | 25 M€ | +17.36% | ||
0.79% | 5 M€ | -.--% | - | |
0.54% | 15,324 M€ | +14.73% | - | |
0.53% | 28,258 M€ | +15.67% | - | |
0.50% | 25 M€ | +4.02% | - | |
0.46% | 727 M€ | +8.46% | ||
0.44% | 4 M€ | +17.11% | ||
0.43% | 64,792 M€ | +15.61% | ||
0.35% | 36 M€ | +2.97% | - | |
0.27% | 10 M€ | -3.35% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+2.59% | 42.18B | |
+31.06% | 688B | |
+30.35% | 588B | |
-3.42% | 364B | |
+18.02% | 326B | |
+4.27% | 285B | |
+15.53% | 239B | |
+10.16% | 210B | |
-8.14% | 200B | |
+8.12% | 167B |
- Stock Market
- Equities
- 4502 Stock
- Funds and ETFs Takeda Pharmaceutical Company Limited